Related Experiment Video
Updated: May 31, 2026

Genetically-encoded Molecular Probes to Study G Protein-coupled Receptors
Published on: September 13, 2013
Laboratory of receptor pharmacology
1Neurologic Care Associates, MacNeal Hospital, 3340 S. Oak Park Avenue Suite 200, Berwyn, IL 60402, United States. wwojcik@macneal.com
Abstract:
The Laboratory of Receptor Pharmacology studied the GABAB and muscarinic m2/m3 receptors present in primary cultures of rat cerebellar granule cells. From 1985 to 1992, multiple scientists showed the GABAB receptor had, at least, two affinity states, the low affinity receptor inhibiting adenylyl cyclase and the higher affinity receptor increasing intracellular calcium from ryanodine sensitive calcium stores. Muscarinic m2 receptors inhibit adenylyl cyclase and would undergo desensitization using, in part, similar mechanism of desensitization identified for the beta-adrenergic receptor coupled to adenylyl cyclase. Muscarinic m3 receptors increased intracellular calcium levels via inositol 3-phosphate-sensitive intracellular calcium stores.
Related Concept Videos
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with one...
Quantitative Aspects of Drug-Receptor Interaction
G-protein Coupled Receptors
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.

